On stand by: Host genetics of HIV control

AIDS

Volumn 27, Issue 18, 2013, Pages 2831-2839

  Carrington, Mary ^a,b   Bashirova, Arman A ^a,b   McLaren, Paul J ^c,d,e  

^a FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c EPFL   (Switzerland)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

Genome wide association study; Host genetics; Human leukocyte antigen

Indexed keywords

CHEMOKINE RECEPTOR CCR5; HLA ANTIGEN CLASS 1; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LEUKOCYTE ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; GENE DELETION; GENE DOSAGE; GENE INSERTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOME; HLA SYSTEM; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGLOBULIN GENE; INFECTION CONTROL; LEUKOCYTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REVIEW; SAMPLE SIZE; GENETICS; IMMUNOGENETICS; IMMUNOLOGY; MEDICAL GENETICS; MEDICAL RESEARCH; TRENDS;

BIOMEDICAL RESEARCH; GENETICS, MEDICAL; GENOME-WIDE ASSOCIATION STUDY; HIV INFECTIONS; HUMANS; IMMUNOGENETICS;

EID: 84888266010     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/01.aids.0000432536.85335.c8     Document Type: Review

References (53)

1. Just JJ. Genetic predisposition to HIV-1 infection and acquired immune deficiency virus syndrome: A review of the literature examining associations with HLA [corrected]. Hum Immunol 1995; 44:156-169.
2. Kroner BL, Goedert JJ, Blattner WA, Wilson SE, Carrington MN, Mann DL. Concordance of human leukocyte antigen haplotype-sharing, CD4 decline and AIDS in hemophilic siblings. Multicenter Hemophilia Cohort and Hemophilia Growth and Development Studies. AIDS 1995; 9:275-280.
3. Carrington M, OBrien SJ. The influence of HLA genotype on AIDS. Annu Rev Med 2003; 54:535-551.
4. Dalmasso C, Carpentier W, Meyer L, Rouzioux C, Goujard C, Chaix ML, et al. Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study. PLoS One 2008; 3:e3907.
5. Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, Cirulli ET, et al. Common genetic variation and the control of HIV-1 in humans. PLoS Genet 2009; 5:e1000791.
6. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007; 317:944-947.
7. Guergnon J, Dalmasso C, Broet P, Meyer L, Westrop SJ, Imami N, et al. Single-nucleotide polymorphism-defined class I and class III major histocompatibility complex genetic subregions contribute to natural long-term nonprogression in HIV infection. J Infect Dis 2012; 205:718-724.
8. Le Clerc S, Coulonges C, Delaneau O, Van Manen D, Herbeck JT, Limou S, et al. Screening low-frequency SNPS from genomewide association study reveals a new risk allele for progression to AIDS. J Acquir Immune Defic Syndr 2011; 56:279-284.
9. Limou S, Le Clerc S, Coulonges C, Carpentier W, Dina C, Delaneau O, et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 2009; 199:419-426.
10. Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010; 330:1551-1557.
11. Gao X, Bashirova A, Iversen AK, Phair J, Goedert JJ, Buchbinder S, et al. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med 2005; 11:1290-1292.
12. Kaslow RA, Carrington M, Apple R, Park L, Munoz A, Saah AJ, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996; 2:405-411.
13. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L, et al. HLA BM5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A 2000; 97:2709-2714.
14. Carrington M, Walker BD. Immunogenetics of spontaneous control of HIV. Annu Rev Med 2012; 63:131-145.
15. McLaren PJ, Ripke S, Pelak K, Weintrob AC, Patsopoulos NA, Jia X, et al. Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans. Hum Mol Genet 2012; 21:4334-4347.
16. Martinez-Naves E, Barber LD, Madrigal JA, Vullo CM, Clayberger C, Lyu SC, et al. Interactions of HLA-BM4801 with peptide and CD8. Tissue Antigens 1997; 50:258-264.
17. Goulder PJ, Walker BD. HIV and HLA class I: An evolving relationship. Immunity 2012; 37:426-440.
18. Kaslow RA, Dorak T, Tang JJ. Influence of host genetic variation on susceptibility to HIV type 1 infection. J Infect Dis 2005; 191 (Suppl 1):S68-S77.
19. Lane J, McLaren PJ, Dorrell L, Shianna KV, Stemke A, Pelak K, et al. A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. Hum Mol Genet 2013.
20. Thomas R, Apps R, Qi Y, Gao X, Male V, OHUigin C, et al. HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet 2009; 41:1290-1294.
21. Zemmour J, Parham P. Distinctive polymorphism at the HLA-C locus: Implications for the expression of HLA-C. J Exp Med 1992; 176:937-950.
22. Snary D, Barnstable CJ, Bodmer WF, Crumpton MJ. Molecular structure of human histocompatibility antigens: the HLA-C series. Eur J Immunol 1977; 7:580-585.
23. McCutcheon JA, Gumperz J, Smith KD, Lutz CT, Parham P. Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J Exp Med 1995; 181:2085-2095.
24. Bashirova AA, Martin MP, McVicar DW, Carrington M. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet 2006; 7:277-300.
25. Cohen GB, Gandhi RT, Davis DM, Mandelboim O, Chen BK, Strominger JL, et al. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999; 10:661-671.
26. Yang OO, Nguyen PT, Kalams SA, Dorfman T, Gottlinger HG, Stewart S, et al. Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes. J Virol 2002; 76:1626-1631.
27. Stranger BE, Forrest MS, Clark AG, Minichiello MJ, Deutsch S, Lyle R, et al. Genome-wide associations of gene expression variation in humans. PLoS Genet 2005; 1:e78.
28. Corrah TW, Goonetilleke N, Kopycinski J, Deeks SG, Cohen MS, Borrow P, et al. Reappraisal of the relationship between the HIV-1-protective single-nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and surface HLA-C expression. J Virol 2011; 85:3367-3374.
29. Apps R, Qi Y, Carlson JM, Chen H, Gao X, Thomas R, et al. Influence of HLA-C expression level on HIV control. Science 2013; 340:87-91.
30. Campbell MC, Tishkoff SA. African genetic diversity: Implications for human demographic history, modern human origins, and complex disease mapping. Annu Rev Genomics Hum Genet 2008; 9:403-433.
31. Kulkarni S, Savan R, Qi Y, Gao X, Yuki Y, Bass SE, et al. Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 2011; 472:495-498.
32. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433:769-773.
33. Giraldez AJ, Mishima Y, Rihel J, Grocock RJ, Van Dongen S, Inoue K, et al. Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs. Science 2006; 312:75-79.
34. WuL, Fan J, Belasco JG. MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci U S A 2006; 103:4034-4039.
35. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010; 466:835-840.
36. Blais ME, Zhang Y, Rostron T, Griffin H, Taylor S, Xu K, et al. High frequency of HIV mutations associated with HLA-C suggests enhanced HLA-C-restricted CTL selective pressure associated with an AIDS-protective polymorphism. J Immunol 2012; 188:4663-4670.
37. Bender K. The HLA-A:HLA-B crossovers and their contribution in analysing possible haplotype-specific recombination rates. Hum Genet 1982; 61:127-134.
38. Rose M, Menzel GR, Geserick G, Doxiadis G, Grosse-Wilde H, Mukaida M, et al. Recombination within the class III region by a double cross over event. Tissue Antigens 1988; 31:183-190.
39. Bouissou C, Pontarotti P, Crouau-Roy B. A precise meiotic map in the class I region of the human major histocompatibility complex. Genomics 1995; 30:486-492.
40. Wu TC, Lichten M. Factors that affect the location and frequency of meiosis-induced double-strand breaks in Saccharomyces cerevisiae. Genetics 1995; 140:55-66.
41. Parham P, Lawlor DA, Lomen CE, Ennis PD. Diversity and diversification of HLA-A,B,C alleles. J Immunol 1989; 142: 3937-3950.
42. Hughes AL, Hughes MK, Watkins DI. Contrasting roles of interallelic recombination at the HLA-A and HLA-B loci. Genetics 1993; 133:669-680.
43. Carrington M, Martin MP, van Bergen J. KIR-HLA intercourse in HIV disease. Trends Microbiol 2008; 16:620-627.
44. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002; 31:429-434.
45. Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007; 39:733-740.
46. Pelak K, Need AC, Fellay J, Shianna KV, Feng S, Urban TJ, et al. Copy number variation of KIR genes influences HIV-1 control. PLoS Biol 2011; 9:e1001208.
47. Ahuja SK, Kulkarni H, Catano G, Agan BK, Camargo JF, He W, et al. CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals. Nat Med 2008; 14:413-420.
48. Bhattacharya T, Stanton J, Kim EY, Kunstman KJ, Phair JP, Jacobson LP, et al. CCL3L1 and HIV/AIDS susceptibility. Nat Med 2009; 15:1112-1115.
49. Field SF, Howson JM, Maier LM, Walker S, Walker NM, Smyth DJ, et al. Experimental aspects of copy number variant assays at CCL3L1. Nat Med 2009; 15:1115-1117.
50. He W, Kulkarni H, Castiblanco J, Shimizu C, Aluyen U, Maldonado R, et al. Reply to: Experimental aspects of copy number variant assays at CCL3L1. Nat Med 2009; 15:1117-1120.
51. Urban TJ, Weintrob AC, Fellay J, Colombo S, Shianna KV, Gumbs C, et al. CCL3L1 and HIV/AIDS susceptibility. Nat Med 2009; 15:1110-1112.
52. Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, et al. Systematic localization of common diseaseassociated variation in regulatory DNA. Science 2012; 337: 1190-1195.
53. Rotger M, Dang KK, Fellay J, Heinzen EL, Feng S, Descombes P, et al. Genome-wide mRNA expression correlates of viral control in CD4R T-cells from HIV-1-infected individuals. PLoS Pathog 2010; 6:e1000781.